| Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis Y Ino, RA Betensky, MC Zlatescu, H Sasaki, DR Macdonald, ... Clinical Cancer Research 7 (4), 839-845, 2001 | 554 | 2001 |
| Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms MC Zlatescu, AR TehraniYazdi, H Sasaki, JF Megyesi, RA Betensky, ... Cancer research 61 (18), 6713-6715, 2001 | 289 | 2001 |
| Long survival and therapeutic responses in patient histologically disparate high-grade gliomas demonstrating chromosome 1p loss Y Ino, MC Zlatescu, H Sasaki, DR Macdonald, AO Stemmer-Rachamimov, ... Journal of neurosurgery 92 (6), 983-990, 2000 | 189 | 2000 |
| PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis H Sasaki, MC Zlatescu, RA Betensky, Y Ino, JG Cairncross, DN Louis The American journal of pathology 159 (1), 359-367, 2001 | 188 | 2001 |
| Imaging correlates of molecular signatures in oligodendrogliomas JF Megyesi, E Kachur, DH Lee, MC Zlatescu, RA Betensky, PA Forsyth, ... Clinical Cancer Research 10 (13), 4303-4306, 2004 | 181 | 2004 |
| TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion K Rostasy, SJ Augood, JW Hewett, JC Leung, H Sasaki, LJ Ozelius, ... Neurobiology of disease 12 (1), 11-24, 2003 | 180 | 2003 |
| The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications R Tamura, T Tanaka, Y Akasaki, Y Murayama, K Yoshida, H Sasaki Medical Oncology 37, 1-14, 2020 | 179 | 2020 |
| Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade “oligodendroglioma” H Sasaki, MC Zlatescu, RA Betensky, LB Johnk, AN Cutone, ... Journal of Neuropathology & Experimental Neurology 61 (1), 58-63, 2002 | 170 | 2002 |
| Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): a phase … T Kayama, S Sato, K Sakurada, J Mizusawa, R Nishikawa, Y Narita, ... Journal of Clinical Oncology 36 (33), 3282-3289, 2018 | 159 | 2018 |
| Dual role of macrophage in tumor immunity R Tamura, T Tanaka, Y Yamamoto, Y Akasaki, H Sasaki Immunotherapy 10 (10), 899-909, 2018 | 120 | 2018 |
| Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response R Tamura, T Tanaka, K Miyake, K Yoshida, H Sasaki Brain tumor pathology 34, 62-77, 2017 | 107 | 2017 |
| Expression of the neural cell adhesion molecule in astrocytic tumors: an inverse correlation with malignancy H Sasaki, K Yoshida, E Ikeda, H Asou, M Inaba, M Otani, T Kawase Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 106 | 1998 |
| Release of ciliary neurotrophic factor from cultured astrocytes and its modulation by cytokines H Kamiguchi, K Yoshida, M Sagoh, H Sasaki, M Inaba, H Wakamoto, ... Neurochemical research 20, 1187-1193, 1995 | 83 | 1995 |
| Pros and cons of using ORBEYE™ for microneurosurgery S Takahashi, M Toda, M Nishimoto, E Ishihara, T Miwa, T Akiyama, ... Clinical Neurology and Neurosurgery 174, 57-62, 2018 | 75 | 2018 |
| Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with … Y Kitamura, H Sasaki, T Kimura, T Miwa, S Takahashi, T Kawase, ... Journal of Neuropathology & Experimental Neurology 72 (9), 814-821, 2013 | 72 | 2013 |
| Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab R Tamura, T Tanaka, K Ohara, K Miyake, Y Morimoto, Y Yamamoto, ... Cancer science 110 (2), 499-508, 2019 | 56 | 2019 |
| JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma T Wakabayashi, A Natsume, J Mizusawa, H Katayama, H Fukuda, M Sumi, ... Journal of neuro-oncology 138, 627-636, 2018 | 53 | 2018 |
| Histopathological investigation of glioblastomas resected under bevacizumab treatment R Tamura, T Tanaka, K Miyake, Y Tabei, K Ohara, O Sampetrean, M Kono, ... Oncotarget 7 (32), 52423, 2016 | 51 | 2016 |
| DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis H Sasaki, RA Betensky, JG Cairncross, DN Louis Cancer research 62 (6), 1790-1796, 2002 | 50 | 2002 |
| Lipomas of the frontal lobe H Sasaki, K Yoshida, H Wakamoto, M Otani, S Toya Clinical neurology and neurosurgery 98 (1), 27-31, 1996 | 41 | 1996 |
